Medindia LOGIN REGISTER
Medindia

Ranbaxy Launches Pravastatin Sodium Tablets in US

by VR Sreeraman on Jun 25 2007 8:34 PM

Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases.

Mumbai, June 25 (IANS) Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases.

Being the first-to-file, the company will enjoy a 180-day exclusivity for the pravastatin 80mg and benefit from the commercial gains during the period, it informed the Bombay Stock Exchange (BSE).

The annual sales for the tablets, used for prevention of several types coronary heart diseases, were $209 million, it said.

Source-IANS
LIN/S


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional